Hsu LH - Search Results

1

Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy.

Huang CY, Hsu LH, Chen CY, Chang GC, Chang HW, Hung YM, Liu KJ, Kao SH. Huang CY, et al. Among authors: hsu lh. Cancers (Basel). 2020 Jan 10;12(1):181. doi: 10.3390/cancers12010181. Cancers (Basel). 2020. PMID: 31936895 Free PMC article.

2

Estrogen adversely affects the prognosis of patients with lung adenocarcinoma.

Hsu LH, Liu KJ, Tsai MF, Wu CR, Feng AC, Chu NM, Kao SH. Hsu LH, et al. Cancer Sci. 2015 Jan;106(1):51-9. doi: 10.1111/cas.12558. Epub 2014 Nov 28. Cancer Sci. 2015. PMID: 25338663 Free PMC article.

3

Estrogen, Estrogen Receptor and Lung Cancer.

Hsu LH, Chu NM, Kao SH. Hsu LH, et al. Int J Mol Sci. 2017 Aug 5;18(8):1713. doi: 10.3390/ijms18081713. Int J Mol Sci. 2017. PMID: 28783064 Free PMC article. Review.

4

G-Protein Coupled Estrogen Receptor in Breast Cancer.

Hsu LH, Chu NM, Lin YF, Kao SH. Hsu LH, et al. Int J Mol Sci. 2019 Jan 14;20(2):306. doi: 10.3390/ijms20020306. Int J Mol Sci. 2019. PMID: 30646517 Free PMC article. Review.

5

The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis.

Hsu LH, Soong TC, Chu NM, Huang CY, Kao SH, Lin YF. Hsu LH, et al. J Clin Med. 2020 Dec 11;9(12):4010. doi: 10.3390/jcm9124010. J Clin Med. 2020. PMID: 33322487 Free PMC article.

6

Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.

Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC, Chen CY, Chen KC, Yang TY, Chou TY, Wang WH, Whang-Peng J, Shih NY. Chang GC, et al. Among authors: hsu lh. Clin Cancer Res. 2006 Oct 1;12(19):5746-54. doi: 10.1158/1078-0432.CCR-06-0324. Clin Cancer Res. 2006. PMID: 17020980

7

Second primary lung cancers among breast cancer patients treated with anti-estrogens have a longer cancer-specific survival.

Hsu LH, Feng AC, Kao SH, Liu CC, Tsai SY, Shih LS, Chu NM. Hsu LH, et al. Anticancer Res. 2015 Feb;35(2):1121-7. Anticancer Res. 2015. PMID: 25667502

8

Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.

Hsu LH, Hsu PC, Liao TL, Feng AC, Chu NM, Kao SH. Hsu LH, et al. Among authors: hsu pc. BMC Cancer. 2016 Jul 13;16:463. doi: 10.1186/s12885-016-2529-1. BMC Cancer. 2016. PMID: 27411914 Free PMC article.

9

Clinical outcomes of chemical pleurodesis using a minocycline.

Hsu LH, Feng AC, Soong TC, Ko JS, Chu NM, Lin YF, Kao SH. Hsu LH, et al. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619841231. doi: 10.1177/1753466619841231. Ther Adv Respir Dis. 2019. PMID: 30945619 Free PMC article.

10

Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?

Hsu LH, Chu NM, Liu CC, Tsai SY, You DL, Ko JS, Lu MC, Feng AC. Hsu LH, et al. Lung Cancer. 2009 Nov;66(2):262-7. doi: 10.1016/j.lungcan.2009.01.020. Epub 2009 Mar 18. Lung Cancer. 2009. PMID: 19299032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page